Pancreatic Adenocarcinoma Treatment Market - Top Companies and Manufacturers

Companies Dominating the Pancreatic Adenocarcinoma Treatment Landscape

Amgen Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
F. Hoffman-La Roche AG
Novartis AG
Pfizer Inc.
Aduro Biotech Inc.
Clovis Oncology Inc.
Threshold Pharmaceuticals Inc.
NewLink Genetics Corp
Infinity Pharmaceuticals Inc.
Celgene Corporation

Browse Key Market Insights with Data Illustration:

Pancreatic Adenocarcinoma Treatment Market Size & Share, Growth Trends 2037

In the News

Amgen Inc.’s new drug targeting KRAS mutations was approved by the U.S. Food and Drug Administration. This is the first-ever therapy developed to treat KRAS cancers, which are often altered in the colon, lung, and pancreatic areas.
Novartis AG declared that US Food and Drug Administration granted the NIS793 with Orphan Drug Designation (ODD) along with standard chemotherapy care for the treatment of pancreatic cancer.

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of pancreatic adenocarcinoma treatment is evaluated at USD 2.92 billion.

The pancreatic adenocarcinoma treatment market size was valued at USD 2.62 billion in 2024 and is expected to reach USD 14.89 billion by 2037, registering around 14.3% CAGR during the forecast period i.e., between 2025-2037. The market growth is propelled by the increasing geriatric population around the world and the rising prevalence of obesity.

North America industry is expected to hold largest revenue share of 33% by 2037, propelled by increasing prevalence of pancreatic adenocarcinoma disease across the region.

The major players in the market include Amgen Inc., F. Hoffman-La Roche AG, Novartis AG, Pfizer Inc., Aduro Biotech Inc., Clovis Oncology Inc., Threshold Pharmaceuticals Inc., NewLink Genetics Corp, Infinity Pharmaceuticals Inc., Celgene Corporation

Pancreatic Adenocarcinoma Treatment Market - Top Companies and Manufacturers

Companies Dominating the Pancreatic Adenocarcinoma Treatment Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How much is the pancreatic adenocarcinoma treatment market worth?

Why is the demand for pancreatic adenocarcinoma treatment growing?

Which region dominated the majority of pancreatic adenocarcinoma treatment industry share?

Who are the top pancreatic adenocarcinoma treatment companies?